Cellular therapies supplement: Strategies for improving transplant efficiency in the context of cellular therapeutics

Antonio Jimenez, Henry C. Fung, Kent W. Christopherson

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The field of hematopoietic stem cell transplantation (HSCT) has overcome many obstacles that have led to our current clinical ability to utilize cells collected from marrow, mobilized peripheral blood, or umbilical cord blood for the treatment of malignant and nonmalignant hematologic diseases. It is in this context that it becomes evident that future progress will lie in our development of an understanding of the biology by which the process of HSCT is regulated. By understanding the cellular components and the mechanisms by which HSCT is either enhanced or suppressed it will then be possible to design therapeutic strategies to improve rates of engraftment that will have a positive impact on immune reconstitution post-HSCT. In this review we focus primarily on allogeneic hematopoietic stem cell transplantation (allo-HSCT), the current challenges associated with allo-HSCT, and some developing strategies to improve engraftment in this setting.

Original languageEnglish (US)
Pages (from-to)125S-137S
JournalTransfusion
Volume51
Issue numberSUPPL. 4
DOIs
StatePublished - Nov 2011
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Hematology

Fingerprint

Dive into the research topics of 'Cellular therapies supplement: Strategies for improving transplant efficiency in the context of cellular therapeutics'. Together they form a unique fingerprint.

Cite this